Autobio Diagnostics Co

Autobio Diagnostics Co Diluted EPS

The Diluted Earnings per Share of Autobio Diagnostics Co (603658.SS) as of Oct 16, 2026 is 1.87 CNY. In the previous year, Diluted Earnings per Share was 2.08 CNY — a change of -10.13% (lower).

Diluted EPS

1.87CNY

YoY

-10.13%

Last updated:

Diluted Earnings per Share of Autobio Diagnostics Co is 2025 1.87 CNY. Diluted Earnings per Share of Autobio Diagnostics Co was 2024 2.08 CNY. It decreases by -10.13% lower compared to the previous year.

The Autobio Diagnostics Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
1.03 CNY
Jan 1, 2019
1.42 CNY
Jan 1, 2020
1.34 CNY
Jan 1, 2021
1.67 CNY
Jan 1, 2022
1.99 CNY
Jan 1, 2023
2.10 CNY
Jan 1, 2024
2.08 CNY
Jan 1, 2025
1.87 CNY
The Autobio Diagnostics Co Diluted EPS history
YEARDiluted EPSYoY
1.87CNY-10.13%
2.08CNY-0.75%
2.10CNY+5.23%
1.99CNY+19.46%
1.67CNY+24.37%
1.34CNY-5.79%
1.42CNY+38.57%
1.03CNY+27.45%
0.81CNY+14.52%
0.70CNY+26.62%
0.56CNY+52.47%
0.36CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co Ltd, listed on the Shanghai Stock Exchange under ticker 603658.SS, is a healthcare company based in Zhengzhou, China. The company specializes in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. With a workforce of 5,505 employees, Autobio Diagnostics went public on September 1, 2016. Its product portfolio includes immunodiagnostic reagents such as microplate chemiluminescence diagnostic reagents, enzyme-linked immunosorbent assay (ELISA) diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The company also offers microbiology detection products, including training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products encompass microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. Autobio Diagnostics primarily serves domestic markets within China, focusing on providing diagnostic solutions for healthcare applications. The company's headquarters is located in Zhengzhou, Henan Province, and it operates within the healthcare sector, specifically in the health care industry. Its website, https://www.autobio.com.cn/, provides further information on its services and products. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Diluted Earnings per Share of Autobio Diagnostics Co is 1.87 CNY in 2025.

Diluted Earnings per Share of Autobio Diagnostics Co changed from 2.08 CNY to 1.87 CNY, representing a -10.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Autobio Diagnostics Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Autobio Diagnostics Co